RinuaGene Biotechnology
PrivateCompany Overview
RinuaGene Biotechnology operates in Healthcare & Life Sciences and is based in Suzhou. It was founded in 2021.
RinuaGene Biotechnology is a biotechnology company that develops innovative mRNA-based therapeutics and vaccines for oncology and infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RinuaGene Biotechnology Comparables
Compare RinuaGene Biotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| RiboX Therapeutics | 85% | |
| Therorna Inc. | 84% | |
| Immorna Biotherapeutics | 84% |
For institutional investors. Book with your work email.
RinuaGene Biotechnology Funding Rounds
Historical fundraising activity
RinuaGene Biotechnology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about RinuaGene Biotechnology's valuation, stock price, and market status.
Is RinuaGene Biotechnology a public or private company?
RinuaGene Biotechnology is a private company.
What is the current stock price of RinuaGene Biotechnology?
RinuaGene Biotechnology is a private company, so its shares have no public market price. Caplight tracks RinuaGene Biotechnology's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is RinuaGene Biotechnology worth (valuation)?
Valuation information for RinuaGene Biotechnology is not publicly available.
Can I buy RinuaGene Biotechnology stock?
RinuaGene Biotechnology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was RinuaGene Biotechnology's last funding round?
Funding round information for RinuaGene Biotechnology is not publicly available.
Who are the main investors in RinuaGene Biotechnology?
Investor information for RinuaGene Biotechnology is not publicly disclosed.
Will RinuaGene Biotechnology IPO soon?
No public IPO plans have been announced for RinuaGene Biotechnology.
How can I track RinuaGene Biotechnology secondary market activity?
Caplight tracks bids, offers, and trades in RinuaGene Biotechnology's shares on secondary markets.